Improving treatment and quality of life for head and neck cancer patients
Colorado Head and Neck Cancer SPORE
This study is looking for better ways to help people with head and neck cancer live longer and feel better by testing new treatments, including exciting immunotherapy options and combinations of radiation with special medicines, and patients might get a chance to join in on these trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11072486 on NIH RePORTER |
What this research studies
This research focuses on enhancing the survival and quality of life for patients with head and neck cancer (HNC) by exploring new treatment methods. It utilizes advanced model systems to identify molecular and cellular mechanisms involved in HNC, aiming to develop targeted therapies. The research includes projects that investigate novel immunotherapy approaches and the effects of combining radiation therapy with specific inhibitors to boost the immune response against cancer. Patients may have the opportunity to participate in clinical trials assessing these innovative treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with head and neck cancer, particularly those with head and neck squamous cell carcinoma.
Not a fit: Patients with cancers unrelated to the head and neck region may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for head and neck cancer, improving patient outcomes and quality of life.
How similar studies have performed: Previous research has shown promise in using immunotherapy and targeted treatments for head and neck cancers, indicating potential for success in this approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Jimeno, Antonio — University of Colorado Denver
- Study coordinator: Jimeno, Antonio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.